{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:39:19Z","timestamp":1790973559300,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85847-w","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T05:33:08Z","timestamp":1736487188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ultra-early indicators of acute hypertriglyceridemic pancreatitis may influence treatment decision-making"],"prefix":"10.1038","volume":"15","author":[{"given":"Jing","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiyong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"85847_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","volume":"62","author":"PA Banks","year":"2013","unstructured":"Banks, P. A. et al. Classification of acute pancreatitis\u20132012: revision of the Atlanta classification and definitions by international consensus. Gut 62, 102\u2013111 (2013).","journal-title":"Gut"},{"key":"85847_CR2","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMra1505202","volume":"375","author":"CE Forsmark","year":"2016","unstructured":"Forsmark, C. E., Vege, S. S. & Wilcox, C. M. Acute pancreatitis. N. Engl. J. Med. 375, 1972\u20131981 (2016).","journal-title":"N Engl. J. Med."},{"key":"85847_CR3","doi-asserted-by":"crossref","unstructured":"Li, J. et al. Interleukin-6 is better than C-reactive protein for the prediction of infected pancreatic necrosis and mortality in patients with acute pancreatitis. Front. Cell. Infect. Microbiol.  12. (2022).","DOI":"10.3389\/fcimb.2022.933221"},{"key":"85847_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/MPA.0000000000000776","volume":"46","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y. et al. A study on the etiology, severity, and mortality of 3260 patients with acute pancreatitis according to the revised Atlanta classification in Jiangxi, China over an 8-Year period. Pancreas 46, 504\u2013509 (2017).","journal-title":"Pancreas"},{"key":"85847_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/ajg.2015.261","volume":"110","author":"H Nawaz","year":"2015","unstructured":"Nawaz, H. et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am. J. Gastroenterol. 110, 1497\u20131503 (2015).","journal-title":"Am. J. Gastroenterol."},{"key":"85847_CR6","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/MPA.0000000000000860","volume":"46","author":"LY Sue","year":"2017","unstructured":"Sue, L. Y. et al. Effect of serum triglycerides on clinical outcomes in Acute Pancreatitis: findings from a Regional Integrated Health Care System. Pancreas 46, 874\u2013879 (2017).","journal-title":"Pancreas"},{"key":"85847_CR7","doi-asserted-by":"crossref","unstructured":"Kiss, L. et al. Mechanisms Linking Hypertriglyceridaemia to Acute Pancreatitis  e13916 (Acta physiologica, 2023).","DOI":"10.1111\/apha.13916"},{"key":"85847_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","volume":"380","author":"DL Bhatt","year":"2019","unstructured":"Bhatt, D. L. et al. Cardiovascular risk reduction with Icosapent ethyl for hypertriglyceridemia. N. Engl. J. Med. 380, 11\u201322 (2019).","journal-title":"N Engl. J. Med."},{"key":"85847_CR9","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1001\/jama.2020.22258","volume":"324","author":"SJ Nicholls","year":"2020","unstructured":"Nicholls, S. J. et al. Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH randomized clinical trial. Jama 324, 2268\u20132280 (2020).","journal-title":"Jama"},{"key":"85847_CR10","first-page":"117","volume":"15","author":"RJ Havel","year":"1969","unstructured":"Havel, R. J. Pathogenesis, differentiation and management of hypertriglyceridemia. Adv. Intern. Med. 15, 117\u2013154 (1969).","journal-title":"Adv. Intern. Med."},{"key":"85847_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.ejim.2014.08.008","volume":"25","author":"P Valdivielso","year":"2014","unstructured":"Valdivielso, P., Ram\u00edrez-Bueno, A. & Ewald, N. Current knowledge of hypertriglyceridemic pancreatitis. Eur. J. Intern. Med. 25, 689\u2013694 (2014).","journal-title":"Eur. J. Intern. Med."},{"key":"85847_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12876-019-0989-x","volume":"19","author":"J Wan","year":"2019","unstructured":"Wan, J. et al. Serum D-dimer levels at admission for prediction of outcomes in acute pancreatitis. BMC Gastroenterol. 19, 67 (2019).","journal-title":"BMC Gastroenterol."},{"key":"85847_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.ajem.2017.02.006","volume":"35","author":"T Peng","year":"2017","unstructured":"Peng, T. et al. Serum calcium as an indicator of persistent organ failure in acute pancreatitis. Am. J. Emerg. Med. 35, 978\u2013982 (2017).","journal-title":"Am. J. Emerg. Med."},{"key":"85847_CR14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/jcb.26222","volume":"119","author":"N Li","year":"2018","unstructured":"Li, N., Wang, B. M., Cai, S. & Liu, P. L. The role of serum high mobility group box 1 and interleukin-6 levels in acute pancreatitis: a meta-analysis. J. Cell. Biochem. 119, 616\u2013624 (2018).","journal-title":"J. Cell. Biochem."},{"key":"85847_CR15","doi-asserted-by":"crossref","unstructured":"Kolber, W. et al. Does the automatic measurement of interleukin 6 allow for prediction of complications during the first 48\u00a0h of acute pancreatitis? Int. J. Mol. Sci.  19  (2018).","DOI":"10.3390\/ijms19061820"},{"key":"85847_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12876-020-01268-1","volume":"20","author":"W Shu","year":"2020","unstructured":"Shu, W. et al. Initially elevated arterial lactate as an independent predictor of poor outcomes in severe acute pancreatitis. BMC Gastroenterol. 20, 116 (2020).","journal-title":"BMC Gastroenterol."},{"key":"85847_CR17","doi-asserted-by":"publisher","first-page":"e004721","DOI":"10.1136\/bmjopen-2013-004721","volume":"4","author":"J Yao","year":"2014","unstructured":"Yao, J. & Lv, G. Association between red cell distribution width and acute pancreatitis: a cross-sectional study. BMJ Open 4, e004721 (2014).","journal-title":"BMJ open."},{"key":"85847_CR18","doi-asserted-by":"publisher","first-page":"4739","DOI":"10.3748\/wjg.v25.i32.4739","volume":"25","author":"FX Zhang","year":"2019","unstructured":"Zhang, F. X., Li, Z. L., Zhang, Z. D. & Ma, X. C. Prognostic value of red blood cell distribution width for severe acute pancreatitis. World J. Gastroenterol. 25, 4739\u20134748 (2019).","journal-title":"World J. Gastroenterol."},{"key":"85847_CR19","doi-asserted-by":"publisher","first-page":"1834256","DOI":"10.1155\/2016\/1834256","volume":"2016","author":"L Yang","year":"2016","unstructured":"Yang, L. et al. Comparison of BISAP, Ranson, MCTSI, and APACHE II in predicting severity and prognoses of hyperlipidemic acute pancreatitis in Chinese patients. Gastroenterol. Res. Pract. 2016, 1834256 (2016).","journal-title":"Gastroenterol. Res. Pract."},{"key":"85847_CR20","first-page":"4232","volume":"16","author":"X Cao","year":"2018","unstructured":"Cao, X. et al. Early predictors of hyperlipidemic acute pancreatitis. Exp.  Ther.  Med. 16, 4232\u20134238 (2018).","journal-title":"Experimental Therapeutic Med."},{"key":"85847_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000095425","volume":"73","author":"AV Kyriakidis","year":"2006","unstructured":"Kyriakidis, A. V. et al. Management of acute severe hyperlipidemic pancreatitis. Digestion 73, 259\u2013264 (2006).","journal-title":"Digestion"},{"key":"85847_CR22","first-page":"53","volume":"70","author":"JL Cameron","year":"1971","unstructured":"Cameron, J. L., Crisler, C., Margolis, S., DeMeester, T. R. & Zuidema, G. D. Acute pancreatitis with hyperlipemia. Surgery 70, 53\u201361 (1971).","journal-title":"Surgery"},{"key":"85847_CR23","first-page":"2134","volume":"90","author":"MR Fortson","year":"1995","unstructured":"Fortson, M. R., Freedman, S. N. & Webster, P. D. 3 Clinical assessment of hyperlipidemic pancreatitis. Am. J. Gastroenterol. 90, 2134\u20132139 (1995).","journal-title":"Am. J. Gastroenterol."},{"key":"85847_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/01.mcg.0000436438.60145.5a","volume":"48","author":"J Scherer","year":"2014","unstructured":"Scherer, J., Singh, V. P., Pitchumoni, C. S. & Yadav, D. Issues in hypertriglyceridemic pancreatitis: an update. J. Clin. Gastroenterol. 48, 195\u2013203 (2014).","journal-title":"J. Clin. Gastroenterol."},{"key":"85847_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MPA.0b013e3181c3c954","volume":"39","author":"XS Lu","year":"2010","unstructured":"Lu, X. S. et al. Effect of lower-molecular weight heparin in the prevention of pancreatic encephalopathy in the patient with severe acute pancreatitis. Pancreas 39, 516\u2013519 (2010).","journal-title":"Pancreas"},{"key":"85847_CR26","doi-asserted-by":"crossref","unstructured":"Carr, R. A., Rejowski, B. J., Cote, G. A., Pitt, H. A. & Zyromski, N. J. Systematic review of hypertriglyceridemia-induced acute pancreatitis: a more virulent etiology?. Pancreatol. Official J. Int.  Associ.  Pancreatol.  (IAP) [et al].  16  469\u2013476. (2016).","DOI":"10.1016\/j.pan.2016.02.011"},{"key":"85847_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/2042018817695449","volume":"8","author":"K Joglekar","year":"2017","unstructured":"Joglekar, K., Brannick, B., Kadaria, D. & Sodhi, A. Therapeutic plasmapheresis for hypertriglyceridemia-associated acute pancreatitis: case series and review of the literature. Therapeutic Adv. Endocrinol. Metab. 8, 59\u201365 (2017).","journal-title":"Therapeutic Adv. Endocrinol. Metabolism"},{"key":"85847_CR28","doi-asserted-by":"crossref","unstructured":"Titcomb, T. J. et al. rd, Eating pattern and nutritional risks among people with multiple sclerosis following a modified paleolithic diet. Nutrients  12. (2020).","DOI":"10.3390\/nu12061844"},{"key":"85847_CR29","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.jacl.2018.08.003","volume":"12","author":"J Oscarsson","year":"2018","unstructured":"Oscarsson, J. et al. Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: a double-blind, randomized, placebo-controlled study. J. Clin. Lipidol. 12, 1390\u20131403e1394 (2018).","journal-title":"J. Clin. Lipidol."},{"key":"85847_CR30","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.cgh.2006.11.023","volume":"5","author":"N Badalov","year":"2007","unstructured":"Badalov, N. et al. Drug-induced acute pancreatitis: an evidence-based review. Clin. Gastroenterol. Hepatol.  Official Clin. Pract. J. Am. Gastroenterol. Assoc.  5, 648\u2013661 (2007).","journal-title":"Clin. Gastroenterol. Hepatology: Official Clin. Pract. J. Am. Gastroenterological Association"},{"key":"85847_CR31","doi-asserted-by":"crossref","unstructured":"Chen, G. et al. Nanoparticles Fueled by Enzyme for the Treatment of Hyperlipidemic Acute Pancreatitis (ACS biomaterials science & engineering, 2024).","DOI":"10.1021\/acsbiomaterials.4c00474"},{"key":"85847_CR32","doi-asserted-by":"publisher","first-page":"108315","DOI":"10.1016\/j.intimp.2021.108315","volume":"101","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Baicalein alleviates pyroptosis and inflammation in hyperlipidemic pancreatitis by inhibiting NLRP3\/Caspase-1 pathway through the miR-192-5p\/TXNIP axis. Int. Immunopharmacol. 101, 108315 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"85847_CR33","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.2147\/JIR.S459258","volume":"17","author":"Y Lin","year":"2024","unstructured":"Lin, Y. et al. Development and validation of a nomogram for predicting the severity of the first episode of hyperlipidemic acute pancreatitis. J. Inflamm. Res. 17, 3211\u20133223 (2024).","journal-title":"J. Inflamm. Res."},{"key":"85847_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12944-024-02057-5","volume":"23","author":"W Zhou","year":"2024","unstructured":"Zhou, W. et al. Analysis of the clinical profile and treatment efficiency of hyperlipidemic acute pancreatitis. Lipids Health Dis. 23, 70 (2024).","journal-title":"Lipids Health Dis."},{"key":"85847_CR35","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.ajem.2018.01.092","volume":"36","author":"J Lu","year":"2018","unstructured":"Lu, J. et al. Penta-therapy for severe acute hyperlipidemic pancreatitis. Am. J. Emerg. Med. 36, 1789\u20131795 (2018).","journal-title":"Am. J. Emerg. Med."},{"key":"85847_CR36","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.pan.2024.08.007","volume":"24","author":"F Ji","year":"2024","unstructured":"Ji, F. et al. A nomogram to predict the occurrence of pseudocyst in patients with acute pancreatitis. Pancreatol. Off.  J. Int. Assoc.  Pancreatol.  (IAP) [et al]  24, 863\u2013869 (2024).","journal-title":"Pancreatology: Official J. Int. Association Pancreatology (IAP) [et al]"},{"key":"85847_CR37","first-page":"101","volume":"27","author":"YY Guo","year":"2019","unstructured":"Guo, Y. Y., Li, H. X., Zhang, Y. & He, W. H. Hypertriglyceridemia-induced acute pancreatitis: progress on disease mechanisms and treatment modalities. Discov. Med. 27, 101\u2013109 (2019).","journal-title":"Discov. Med."},{"key":"85847_CR38","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/joim.13016","volume":"287","author":"A Baass","year":"2020","unstructured":"Baass, A., Paquette, M., Bernard, S. & Hegele, R. A. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia. J. Intern. Med. 287, 340\u2013348 (2020).","journal-title":"J. Intern. Med."},{"key":"85847_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","volume":"272","author":"RP Surendran","year":"2012","unstructured":"Surendran, R. P. et al. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. J. Intern. Med. 272, 185\u2013196 (2012).","journal-title":"J. Intern. Med."},{"issue":"11","key":"85847_CR40","first-page":"2196","volume":"10","author":"MA Cozma","year":"2022","unstructured":"Cozma, M. A. et al. Implications of type 2 diabetes mellitus in patients with acute cholangitis: a systematic review of current literature. Healthcare. (Basel) 10 (11), 2196 (2022).","journal-title":"Healthc. (Basel)"},{"issue":"4","key":"85847_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/1871530321666210924124336","volume":"22","author":"G Lisco","year":"2022","unstructured":"Lisco, G. et al. Hyperglycemia-induced immune system disorders in diabetes mellitus and the concept of hyperglycemic memory of innate immune cells: a perspective. Endocr. Metab. Immune Disord. Drug Targets  22 (4), 367\u2013370 (2022).","journal-title":"Endocr. Metab. Immune Disord Drug Targets"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85847-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85847-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85847-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T06:03:45Z","timestamp":1736489025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85847-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85847"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85847-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The informed consent was waived by the Ethics Committee of the Second Affiliated Hospital, Fujian Medical University(Approval number:2021\u2009\u2212\u2009215) because of the retrospective nature of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The present study was approved by the ethical review committee of the Second Affiliated Hospital, Fujian Medical University (Quanzhou, China). (Approval number: 2021\u2009\u2212\u2009215).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"1572"}}